Possible relationship between drug exposure and multiple sclerosis (MS) development is insufficiently investigated, and further challenged by the incomplete understanding of MS etiopathogenesis. The study aims to investigate whether drug exposure could contribute to MS, by analyzing worldwide spontaneous reporting archives of adverse drug reaction (ADRs).
Antonazzo, I.C., Raschi, E., Forcesi, E., Riise, T., Bjornevik, K., Baldin, E., et al. (2018). Multiple sclerosis as an adverse drug reaction: clues from the FDA Adverse Event Reporting System. EXPERT OPINION ON DRUG SAFETY, 17(9), 869-874 [10.1080/14740338.2018.1506763].
Multiple sclerosis as an adverse drug reaction: clues from the FDA Adverse Event Reporting System
Antonazzo, Ippazio Cosimo;Raschi, Emanuel;Forcesi, Emanuele;Baldin, Elisa;De Ponti, Fabrizio;Poluzzi, Elisabetta
2018
Abstract
Possible relationship between drug exposure and multiple sclerosis (MS) development is insufficiently investigated, and further challenged by the incomplete understanding of MS etiopathogenesis. The study aims to investigate whether drug exposure could contribute to MS, by analyzing worldwide spontaneous reporting archives of adverse drug reaction (ADRs).File in questo prodotto:
Eventuali allegati, non sono esposti
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
